Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.

PMID:
12671020
2.

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, Hamed A, Howell A, Powles T; IBIS investigators.

Lancet. 2002 Sep 14;360(9336):817-24.

PMID:
12243915
3.
4.

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B; National Surgical Adjuvant Breast and Bowel Project.

JAMA. 2001 Nov 14;286(18):2251-6.

PMID:
11710890
5.

Patient reluctance toward tamoxifen use for breast cancer primary prevention.

Port ER, Montgomery LL, Heerdt AS, Borgen PI.

Ann Surg Oncol. 2001 Aug;8(7):580-5.

PMID:
11508619
6.

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Ste-Marie LG.

Breast Cancer Res Treat. 2001 Jan;65(2):125-34. Erratum in: Breast Cancer Res Treat 2001 May;67(2):191.

PMID:
11261828
7.

Chemoprevention of breast cancer.

Brown PH, Lippman SM.

Breast Cancer Res Treat. 2000 Jul;62(1):1-17. Review.

PMID:
10989982
8.

Breast cancer prevention: a review of current evidence.

Vogel VG.

CA Cancer J Clin. 2000 May-Jun;50(3):156-70. Review.

9.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V.

J Natl Cancer Inst. 1999 Nov 3;91(21):1829-46. Review. Erratum in: J Natl Cancer Inst 2000 Feb 2;92(3):275.

PMID:
10547390
10.

Tamoxifen prevention of breast cancer: an instance of the fingerpost.

Lippman SM, Brown PH.

J Natl Cancer Inst. 1999 Nov 3;91(21):1809-19. Review. No abstract available.

PMID:
10547388
11.

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS.

J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8.

PMID:
10491430
13.

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC.

JAMA. 1999 Jun 16;281(23):2189-97. Erratum in: JAMA 1999 Dec 8;282(22):2124.

PMID:
10376571
14.

The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.

Kinney AY, Richards C, Vernon SW, Vogel VG.

Prev Med. 1998 Sep-Oct;27(5 Pt 1):713-9.

PMID:
9808803
15.

Tamoxifen debate hinges on whose risk is high enough.

Reynolds T.

J Natl Cancer Inst. 1998 Oct 7;90(19):1428-30. No abstract available.

PMID:
9776407
16.

The physician's role in women's decision making about hormone replacement therapy.

Newton KM, Lacroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA.

Obstet Gynecol. 1998 Oct;92(4 Pt 1):580-4.

PMID:
9764632
17.

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N.

J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.

PMID:
9747868
18.

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.

Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J.

Lancet. 1998 Jul 11;352(9122):98-101.

PMID:
9672274
19.

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, Rotmensz N, Boyle P.

Lancet. 1998 Jul 11;352(9122):93-7.

PMID:
9672273
20.

Is tamoxifen effective in prevention of breast cancer?

Pritchard KI.

Lancet. 1998 Jul 11;352(9122):80-1. No abstract available.

PMID:
9672266

Supplemental Content

Support Center